What is the recommended tapering schedule for a patient taking 10 mg of diazepam (diazepam)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diazepam Tapering Schedule for 10 mg Daily Dose

For patients taking 10 mg of diazepam daily, the recommended tapering schedule is a gradual reduction of 0.5-1 mg every 4 weeks, with a total tapering period of approximately 20-40 weeks to minimize withdrawal symptoms and maximize successful discontinuation. 1

Detailed Tapering Protocol

Initial Phase (Months 1-3)

  • Start with a reduction of 10% of the original dose (1 mg) every 4 weeks
  • Weeks 1-4: Reduce from 10 mg to 9 mg daily
  • Weeks 5-8: Reduce from 9 mg to 8 mg daily
  • Weeks 9-12: Reduce from 8 mg to 7 mg daily

Middle Phase (Months 4-6)

  • Continue with 1 mg reductions every 4 weeks
  • Weeks 13-16: Reduce from 7 mg to 6 mg daily
  • Weeks 17-20: Reduce from 6 mg to 5 mg daily
  • Weeks 21-24: Reduce from 5 mg to 4 mg daily

Final Phase (Months 7-10)

  • Slow the taper to 0.5 mg reductions every 4 weeks as lower doses are reached
  • Weeks 25-28: Reduce from 4 mg to 3.5 mg daily
  • Weeks 29-32: Reduce from 3.5 mg to 3 mg daily
  • Weeks 33-36: Reduce from 3 mg to 2.5 mg daily
  • Weeks 37-40: Reduce from 2.5 mg to 2 mg daily

Terminal Phase (Months 11-12)

  • Further slow the taper for the final doses
  • Weeks 41-44: Reduce from 2 mg to 1.5 mg daily
  • Weeks 45-48: Reduce from 1.5 mg to 1 mg daily
  • Weeks 49-52: Reduce from 1 mg to 0.5 mg daily
  • Weeks 53-56: Discontinue completely

Monitoring and Adjustment Considerations

  • Follow up with patients at least monthly during tapering to monitor for withdrawal symptoms 1

  • If withdrawal symptoms become intolerable:

    • Pause the taper
    • Maintain the current dose for 1-2 months
    • Resume tapering at a slower rate when symptoms subside 1
  • Common withdrawal symptoms to monitor for:

    • Anxiety
    • Tremors
    • Insomnia/nightmares
    • Excessive sweating
    • Tachycardia/palpitations
    • Headache
    • Muscle aches 2

Special Considerations

  • For elderly patients or those with debilitating disease, start with a lower dose (2-2.5 mg) and taper even more gradually 3
  • If the patient is also taking opioids, coordinate tapering plans carefully as concurrent use increases risk of overdose 4, 3
  • Never abruptly discontinue diazepam due to risk of withdrawal seizures 5
  • For patients who have been on diazepam for many years, consider an even slower taper of 5% reduction every 2-4 weeks 1

Managing Withdrawal Symptoms

  • Consider non-pharmacologic treatments for underlying conditions to help manage withdrawal symptoms 1
  • For severe withdrawal symptoms:
    • α2-adrenergic agonists (clonidine, tizanidine) may help with sympathetic hyperactivity
    • Acetaminophen or NSAIDs for muscle aches
    • Trazodone or mirtazapine may be considered for insomnia 1

Patient Education Points

  • Explain that withdrawal symptoms may occur but can be managed with proper tapering
  • Discuss that many patients actually feel and function better following benzodiazepine tapering 1
  • Advise about increased risk for overdose if returning to previously prescribed higher doses 1
  • Cognitive behavioral therapy can be helpful during the tapering process 1

This tapering schedule balances the need to minimize withdrawal symptoms while achieving successful discontinuation within a reasonable timeframe. The slower taper at lower doses recognizes the non-linear relationship between dose reduction and receptor occupancy, which helps reduce withdrawal intensity.

References

Guideline

Tapering of Benzodiazepines and Opioids

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Benzodiazepine withdrawal seizures and management.

The Journal of the Oklahoma State Medical Association, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.